ciprofloxacin has been researched along with Vaginosis, Bacterial in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Vaginosis, Bacterial: Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.
Excerpt | Relevance | Reference |
---|---|---|
"The prevalence of genital mycoplasma infections is very high in women with bacterial vaginosis." | 1.72 | Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon. ( Lendamba, RW; Mbeang Nguema, PP; Mombo, LE; Onanga, R, 2022) |
"Bacterial vaginosis was present in 32% of the women screened, Chlamydia trachomatis was identified in 8%, none tested positive for Neisseria gonorrhoeae." | 1.32 | Should we offer antibiotic prophylaxis post sexual assault? ( Forster, GE; Gibb, AM; McManus, T, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Lendamba, RW | 1 |
Mbeang Nguema, PP | 1 |
Onanga, R | 1 |
Mombo, LE | 1 |
Wang, J | 1 |
Li, B | 1 |
Li, Y | 1 |
Dou, J | 1 |
Hao, Q | 1 |
Tian, Y | 1 |
Wang, H | 1 |
Zhou, C | 1 |
Swidsinski, A | 1 |
Loening-Baucke, V | 1 |
Schulz, S | 1 |
Manowsky, J | 1 |
Verstraelen, H | 1 |
Swidsinski, S | 1 |
Gibb, AM | 1 |
McManus, T | 1 |
Forster, GE | 1 |
Millán Rodríguez, F | 1 |
Rousaud Barón, F | 1 |
Rousaud Barón, A | 1 |
Fredricsson, B | 1 |
Englund, K | 1 |
Nord, CE | 1 |
Weintraub, L | 1 |
6 other studies available for ciprofloxacin and Vaginosis, Bacterial
Article | Year |
---|---|
Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Coinfection; Drug Resistance, Microbial; | 2022 |
BF-30 effectively inhibits ciprofloxacin-resistant bacteria in vitro and in a rat model of vaginosis.
Topics: Animals; Cathelicidins; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Escherich | 2014 |
Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Biomass; Bioreactors; Ciprofloxacin; Clostridioides dif | 2016 |
Should we offer antibiotic prophylaxis post sexual assault?
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Chlamydia t | 2003 |
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)].
Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; D | 2003 |
Could bacterial vaginosis be due to the competitive suppression of lactobacilli by aerobic microorganisms?
Topics: Adult; Bacteria, Aerobic; Ciprofloxacin; Female; Humans; Lactobacillus; Middle Aged; Vaginosis, Bact | 1992 |